(Q53065543)

11 May 2018

title

Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography. (English)

1 reference

11 May 2018

author name string

Sharmila Dorbala

1

1 reference

11 May 2018

Divya Vangala

2

1 reference

11 May 2018

James Semer

3

1 reference

11 May 2018

Christopher Strader

4

1 reference

11 May 2018

John R Bruyere

5

1 reference

11 May 2018

Marcelo F Di Carli

6

1 reference

11 May 2018

Stephen C Moore

7

1 reference

11 May 2018

Rodney H Falk

8

1 reference

11 May 2018

publication date

20 May 2014

1 reference

11 May 2018

number of pages

11

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

11 May 2018

volume

41

1 reference

11 May 2018

issue

9

1 reference

11 May 2018

page(s)

1652-1662

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s00259-014-2787-6

exact match

0 references

cites work

Molecular mechanisms of amyloidosis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2787-6

Transthyretin (TTR) cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2787-6

Inhibiting transthyretin amyloid fibril formation via protein stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2787-6

Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2787-6

Brain amyloid imaging--FDA approval of florbetapir F18 injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2787-6

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2787-6

Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2787-6

Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2787-6

In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2787-6

(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2787-6

Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2787-6

Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2787-6

Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2787-6

Cardiac amyloidosis: a treatable disease, often overlooked

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24841414

12 December 2020

inferred from PubMed ID database lookup

High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24841414

12 December 2020

inferred from PubMed ID database lookup

Non-invasive predictors of survival in cardiac amyloidosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24841414

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00259-014-2787-6

1 reference

11 May 2018

1 reference

11 May 2018